BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33378006)

  • 1. MiR-155 regulates the proliferation and apoptosis of pancreatic cancer cells through targeting SOCS3.
    Wang J; Guo J; Fan H
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12625. PubMed ID: 33378006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3.
    Liu HP; Zhang Y; Liu ZT; Qi H; Zheng XM; Qi LH; Wang JY
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7914. PubMed ID: 32767307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-221 affects proliferation and apoptosis of gastric cancer cells through targeting SOCS3.
    Zhou QY; Peng PL; Xu YH
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7565. PubMed ID: 32744670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.
    Li XD; Li XM; Gu JW; Sun XC
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7577. PubMed ID: 32744682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA SNHG16 functions as an oncogene by sponging miR-200a-3p in pancreatic cancer.
    Guo JQ; Yang ZJ; Wang S; Wu ZZ; Yin LL; Wang DC
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7218. PubMed ID: 32706056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-410 affects the proliferation and apoptosis of lung cancer A549 cells through regulation of SOCS3/JAK-STAT signaling pathway.
    Li M; Zheng R; Yuan FL
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11462. PubMed ID: 33275202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-101 affects proliferation and apoptosis of cervical cancer cells by inhibition of JAK2.
    Wei H; He WR; Chen KM; Wang XW; Yi CJ
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3147. PubMed ID: 33928594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-218 promotes apoptosis of U2OS osteosarcoma cells through targeting BIRC5.
    Wang DZ; Jing SF; Hao SB; Huang XY; Miao QT; Gao JF
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8242. PubMed ID: 32894525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-181a down-regulates MAP2K1 to enhance adriamycin sensitivity in leukemia HL-60 cells.
    Wang JJ; Yu JP
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):11987. PubMed ID: 33336714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.
    Li HL; Liang S; Cui JH; Han GY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7574. PubMed ID: 32744679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA DGCR5 promotes non-small cell lung cancer progression via sponging miR-218-5p.
    Wang J; Shu HZ; Xu CY; Guo SG
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10303. PubMed ID: 33155263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target inhibition on GSK-3β by miR-9 to modulate proliferation and apoptosis of bladder cancer cells.
    Dong ZC; Zhang D; Wang SB; Lin ZQ
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10301. PubMed ID: 33155265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-143 regulates proliferation and apoptosis of myelocytic leukemia cell HL-60 via modulating ERK1.
    Song B; Tang YJ; Zhang WG; Wan CC; Chen Y; Zhang LJ
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9237. PubMed ID: 33015758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-122 regulates cell apoptosis and ROS by targeting DJ-1 in renal ischemic reperfusion injury rat models.
    Qu XH; Zhang K
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7197. PubMed ID: 32706035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-532-5p acts as a tumor suppressor and inhibits glioma cell proliferation by targeting CSF1.
    Wang YP; Liu J; Liu D; Wang XD; Bian AM; Fang DZ; Hui XB
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7206. PubMed ID: 32706044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3.
    Cao HY; Xiao CH; Lu HJ; Yu HZ; Hong H; Guo CY; Yuan JF
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11468. PubMed ID: 33275208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA SNHG14 acts as an oncogene in prostate cancer via targeting miR-613.
    Sun B; Ke KB; Liu DF; Wang Q; Li YN; Chen JH; Zhang JH
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):10919. PubMed ID: 33215403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circ_0067934 functions as an oncogene in breast cancer by targeting Mcl-1.
    Wang JM; Li XJ; Wang J
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7214. PubMed ID: 32706052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin.
    Han GY; Cui JH; Liang S; Li HL
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11464. PubMed ID: 33275204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137.
    Liu JG; Wang HB; Wan G; Yang MZ; Jiang XJ; Yang JY
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9238. PubMed ID: 33015759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.